Report Library
View More
Datamonitor Healthcare Oncology Dis...
October 4, 2022
Follicular Lymphoma KOL Interview –...
September 30, 2022
Follicular Lymphoma KOL Interview –...
September 30, 2022
Wet Age-Related Macular Degeneratio...
September 29, 2022
Wet Age-Related Macular Degeneratio...
September 29, 2022
Wet Age-Related Macular Degeneratio...
September 29, 2022
Datamonitor Healthcare Oncology Dis...
September 26, 2022
Datamonitor Healthcare I&I Disease ...
September 23, 2022
Datamonitor Healthcare Infectious D...
September 23, 2022
Datamonitor Healthcare I&I Disease ...
September 23, 2022
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 10/3/22 | Clovis Oncology (CLVS) | Rubraca for Prostate Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 10/3/22 | Clene (CLNN) | CNM-Au8 for Amyotrophic Lateral Sclerosis (ALS) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/30/22 | Alnylam (ALNY) | Onpattro for Transthyretin Amyloid Cardiomyopathy (ATTR-CM, Wild Type Or Hereditary) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/30/22 | Intercept Pharmaceuticals (ICPT) | Ocaliva for Non-Alcoholic Steatohepatitis (NASH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/30/22 | Zealand Pharma (ZEAL) | Glepaglutide for Short Bowel Syndrome (SBS) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 10/05/22 | Subscribers Only | Subscribers Only | Trial Data - Final Results |
| 10/05/22 | Subscribers Only | Subscribers Only | Trial Data - Final Results |
| 10/05/22 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/05/22 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 10/05/22 | Subscribers Only | Subscribers Only | Trial Announcement - Other |
